Novel COVID-related Anti-inflammatory Therapies

Dear Colleagues,

The COVID-19 pandemic will continue to infect a large portion of the world’s population and cause substantial morbidity and mortality until either an effective vaccine or a useful antiviral therapeutic is developed. To date, potential vaccines have a long lead time for development and their potential efficacy is uncertain given past failures with coronavirus vaccines. Furthermore, there is no approved antiviral therapy for COVID-19 infection. Therefore, alternative approaches must be explored in the hope of diminishing the potential consequences of COVID-19. Since many patients with COVID-19 show a massive cytokine release ("cytokine storm"), anti-inflammatory drugs have been suggested as potential treatments. This Special Issue of Molecules focuses on anti-inflammatory approaches to treat the immune dysregulation in COVID-19.

Prof. Dr. Christian Lehmann
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• SARS-CoV-2
• COVID-19
• infection
• inflammation
• cytokines
• anti-inflammatory therapies